Schnitzler Syndrome: A Dramatic Response to Anakinra

Schnitzler syndrome is a rare acquired systemic disease with a chronic evolution and difficult treatment. We report a 50-year-old woman with Schnitzler syndrome for 10 years, with major impact on her quality of life and refractory to conventional therapies. The patient was started on anakinra, an IL...

Descripción completa

Detalles Bibliográficos
Autores principales: Gouveia, Ana Isabel, Micaelo, Manuela, Pierdomenico, Francesca, Freitas, João Pedro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4906102/
https://www.ncbi.nlm.nih.gov/pubmed/27017618
http://dx.doi.org/10.1007/s13555-016-0108-7
_version_ 1782437361040228352
author Gouveia, Ana Isabel
Micaelo, Manuela
Pierdomenico, Francesca
Freitas, João Pedro
author_facet Gouveia, Ana Isabel
Micaelo, Manuela
Pierdomenico, Francesca
Freitas, João Pedro
author_sort Gouveia, Ana Isabel
collection PubMed
description Schnitzler syndrome is a rare acquired systemic disease with a chronic evolution and difficult treatment. We report a 50-year-old woman with Schnitzler syndrome for 10 years, with major impact on her quality of life and refractory to conventional therapies. The patient was started on anakinra, an IL-1 receptor antagonist, with a rapid and sustained remission of the syndrome manifestations.
format Online
Article
Text
id pubmed-4906102
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-49061022016-06-28 Schnitzler Syndrome: A Dramatic Response to Anakinra Gouveia, Ana Isabel Micaelo, Manuela Pierdomenico, Francesca Freitas, João Pedro Dermatol Ther (Heidelb) Case Report Schnitzler syndrome is a rare acquired systemic disease with a chronic evolution and difficult treatment. We report a 50-year-old woman with Schnitzler syndrome for 10 years, with major impact on her quality of life and refractory to conventional therapies. The patient was started on anakinra, an IL-1 receptor antagonist, with a rapid and sustained remission of the syndrome manifestations. Springer Healthcare 2016-03-26 /pmc/articles/PMC4906102/ /pubmed/27017618 http://dx.doi.org/10.1007/s13555-016-0108-7 Text en © The Author(s) 2016 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Case Report
Gouveia, Ana Isabel
Micaelo, Manuela
Pierdomenico, Francesca
Freitas, João Pedro
Schnitzler Syndrome: A Dramatic Response to Anakinra
title Schnitzler Syndrome: A Dramatic Response to Anakinra
title_full Schnitzler Syndrome: A Dramatic Response to Anakinra
title_fullStr Schnitzler Syndrome: A Dramatic Response to Anakinra
title_full_unstemmed Schnitzler Syndrome: A Dramatic Response to Anakinra
title_short Schnitzler Syndrome: A Dramatic Response to Anakinra
title_sort schnitzler syndrome: a dramatic response to anakinra
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4906102/
https://www.ncbi.nlm.nih.gov/pubmed/27017618
http://dx.doi.org/10.1007/s13555-016-0108-7
work_keys_str_mv AT gouveiaanaisabel schnitzlersyndromeadramaticresponsetoanakinra
AT micaelomanuela schnitzlersyndromeadramaticresponsetoanakinra
AT pierdomenicofrancesca schnitzlersyndromeadramaticresponsetoanakinra
AT freitasjoaopedro schnitzlersyndromeadramaticresponsetoanakinra

Ejemplares similares